Is compass pathways a buy
WebDec 26, 2024 · Despite having an IPO just three months ago, Compass Pathways ( CMPS 5.84%) is already up a staggering 224% from its IPO price of $17. If you invested $10,000 … WebBuy COMPASS Pathways Shares. Compass Pathways Plc (CMPS) is a publicly traded medical care facilities business based in the US. In the week up to 24 February COMPASS Pathways shares plunged 8.41% to a closing position of $8.6. Over the last 12 months, COMPASS Pathways's share price has fallen by 33.55% from $12.16.
Is compass pathways a buy
Did you know?
Web2 days ago · COMPASS Pathways (CMPS) In a report released today, Elemer Piros from EF Hutton reiterated a Buy rating on COMPASS Pathways, with a price target of $38.00. The … WebBuy Compass Pathways Plc Stocks Fact checked Compass Pathways Plc is a medical care facilities business based in the US. Compass Pathways Plc stocks (CMPS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.17 – a decrease of 10.51% over the previous week.
WebJun 28, 2024 · COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. WebNov 18, 2024 · Compass Pathways (NASDAQ: CMPS) raised $146 million with its initial public offering on Sept. 18. While the IPO's price was set at $17, on the first day of trading, …
WebApr 2, 2024 · I reaffirmed a “buy” rating and issued a $38.00 price target on shares of COMPASS Pathways in a report on Tuesday, February 28th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $47.00. COMPASS Pathways Price … Web15 hours ago · Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology …
WebAs of April 6, 2024, the average one-year price target for COMPASS Pathways Plc American Depository Shares is $42.38. The forecasts range from a low of $19.19 to a high of …
WebApr 14, 2024 · Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, COMPASS Pathways has a consensus rating of “Buy” and an average price target of $47.00. google sheets inventory template redditWebApr 6, 2024 · In addition, COMPASS Pathways PLC Sponsored ADR has a VGM Score of F (this is a weighted average of the individual Style Scores which allow you to focus on the … google sheets inventory and salesWeb2 days ago · COMPASS Pathways has an analyst consensus of Strong Buy, with a price target consensus of $44.14. TipRanks has tracked 36,000 company insiders and found that a few of them are better than... google sheets inventory template formsWebSee the Price Targets and Ratings of: All Analysts Top Analysts Premium CMPS Analyst Ratings Strong Buy 7 Ratings 7 Buy 0 Hold 0 Sell Based on 7 analysts giving stock ratings to COMPASS Pathways in the past 3 months CMPS Stock 12 Months Forecast $44.14 (337.90% Upside) google sheets invert y axisWebApr 12, 2024 · COMPASS Pathways isn't enormous, but it's not particularly small either. ... It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your ... google sheets inventory management templateWebCOMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Its focus is on improving the lives of those who are... google sheets intrinsic values of stocksWebThe latest price target for Compass Pathways ( NASDAQ: CMPS) was reported by HC Wainwright & Co. on Friday, March 10, 2024. The analyst firm set a price target for 120.00 expecting CMPS to rise to ... google sheets invert rows